Yahoo Suche Web Suche

Anmelden
  1. www.siemens.com/Life/Science

    AnzeigeBiocontainment - Smart Laboratories - Vivarium Research

    siemens.com wurde im letzten Monat von mehr als 10.000 Nutzern besucht

    Siemens Digitalization & Sustainable Solutions Ensure Labs are Safe, Secure and Compliant. Life Science Solutions from Siemens: Leading the Way in Science. Learn More Today!

    Improve Lab Quality · Secure Environments · Smart Labs · Reduce Carbon Footprint

Suchergebnisse

  1. Suchergebnisse:

  1. www.boerse.de › aktien › Eli-Lilly-AktieEli Lilly AKTIE | Aktienkurs & News | LLY | 858560 – boerse.de

    Vor 2 Tagen · Die Eli Lilly & Co. erforscht, entwickelt, produziert und vertreibt pharmazeutische Produkte. Schwerpunkte liegen auf der Behandlung von Diabetes, Krebserkrankungen, Erkrankungen des...

    • Chemie, Pharma, Bio- und Medizintechnik
    • USA
    • US5324571083
    • 858,6K

  2. www.bizjournals.com › charlotte › newsEli Lilly eyes Concord production start, doubles investment...

    Vor 2 Tagen · Eli Lilly and Co. (NYSE: LLY) is moving closer to a production start at its massive manufacturing campus in Concord. The pharmaceutical giant has also shattered its investment pledge there and ...

  3. www.finanznachrichten.de › nachrichten-aktien › eli-lilly-andELI LILLY AKTIEN News | 858560 Nachrichten

    Vor 4 Tagen · News zur ELI LILLY AKTIE und aktueller Realtime-Aktienkurs Why Eli Lilly shares should be up on its latest news, plus Nvidia keeps rolling.

    • (147)

  4. www.reuters.com › business › healthcare-pharmaceuticalsWeight-loss drug forecasts jump to $150 billion as supply grows

    Vor 3 Tagen · As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly , increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise ...

  5. Videos

    Alle anzeigen

  6. www.pharmtech.com › view › lilly-raises-investment-in-indianaLilly Raises Investment in Indiana Site to $9 Billion to Expand...

    Vor 2 Tagen · Eli Lilly and Company (Lilly) announced on May 24, 2024 that it has raised its investment in its Lebanon, Ind., manufacturing site by $5.3 billion, more than doubling its overall investment from $3.7 billion previously to now $9 billion. The increased funds are intended to boost the company’s manufacturing capacity for APIs used in the production of Zepbound (tirzepatide) injection and ...

  7. pharmaceuticalmanufacturer.media › pharma-manufacturing-newsLilly Increases Manufacturing Investment to $9 Billion at Newest...

    Vor 4 Tagen · Eli Lilly and Company have announced that it has more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing the company's total investment in this site from $3.7 billion to $9 billion.

  8. pharmasource.global › content › newsEli Lilly Announces "Historic" $5.3 Billion Investment in GLP-1...

    Vor 3 Tagen · Eli Lilly has announced a new $5.3 billion investment in its manufacturing site in Lebanon, Indiana, US. This investment increases the firm’s total investment in the site from $3.7 billion to $9 billion. The expansion will increase the manufacturing capacity of active pharmaceutical ingredients (APIs) for Zepbound and Mounjaro, GLP-1 treatments indicated for obesity and type 2 diabetes.